Community

Judy Chou, Ph.D.

President and Chief Executive Officer, AltruBio, Inc.

With over 20 years of experience in drug development and biomanufacturing, Dr. Judy Chou is currently the President, CEO, and Board member of AltruBio, Inc. Before taking on her current roles, she headed the global biotech organization at Bayer Pharmaceuticals, overseeing the development, manufacturing, and distribution of Bayer’s $3+ billion per year biotechnology product portfolio and 2000+ employees and leading the drug development and launch activities for its biologics pipeline. In addition, she serves as the site head for Bayer’s facility in Berkeley, California, which is the largest U.S. manufacturing site in Bayer’s network. She is well recognized by the biomedical industry for her leadership and has received the Most Influential Women in Business Award in 2018 by the San Francisco Business Times. Before Bayer, Dr. Chou held the role of Vice President of Pharmaceutical/Technical Operations at Pfizer, Inc., formerly Medivation, where she led the Development and Manufacturing organizations for both biologics and small molecule products. She was also Vice President of R&D at Tanvex Biopharma, Inc., where Dr. Chou led the development of rich pipeline projects in R&D, manufacturing, and clinical development and operations to enable the success of the company’s IPO. Throughout Dr. Chou’s career, she has achieved significant milestones in protein therapeutic development and multiple filings of BLAs, NDAs, and INDs of novel products, and she is recognized for her work at Genentech, Pfizer (Wyeth), and Abbvie (Abbott), especially in the development of breakthrough technologies in analytical characterization and accelerated product development. Currently, Dr. Chou also serves as the Board of Directors of Akero Therapeutics, Inc. In addition, since 2017, she has been contributing to higher education through her role as an advisor of the UC Berkeley College of Engineering and promoting diversity and inclusion via her advisory board position at Silicon Valley Women in Engineering. Before joining the industry, Dr. Chou was a research faculty member at Harvard University Medical School, focused on cell biology and neuroscience research. Dr. Chou obtained her Ph.D. from Yale University and completed her post-doctoral training at the Max-Planck Institute in Germany.

Community

Judy Chou, Ph.D.

President and Chief Executive Officer, AltruBio, Inc.

Contributions

Q: What’s the key to being a leader in the industry?

Q: What important company milestone do you anticipate reaching in 2022?